Advisory Commission on Drug Abuse and Controlled Substances (Department of Health)
Hawaii Advisory Commission on Drug Abuse and Controlled Substances
AI-Generated Summary
Plain-language overview — always verify with official documents
What's Being Discussed
The Hawaii Advisory Commission on Drug Abuse and Controlled Substances (HACDACS) is holding a public meeting on Tuesday, October 27, 2026, from 9:00 a.m. to 11:00 a.m. The meeting is hybrid — attend in person in Kapolei or join by Zoom (Meeting ID: 817 6510 7554, Passcode: 803177).
- Recap of an educational event on nonmedical cannabis use among Hawaii youth and its mental health impacts
- Whether to reschedule the November 24, 2026 meeting
- Progress on updating the commission's bylaws
- Planning future meeting topics, such as residential treatment programs, virtual substance use services, mental health and addiction overlap, and substance use among active duty military members
- Preparation of the commission's annual report to the Hawaii Legislature, covering topics like telehealth, Medicaid data tools, AI guidelines, and a Second Responder Team pilot program
- A presentation on updated Medicaid eligibility requirements from the Department of Human Services Med-QUEST Division
Decisions Expected
- Approval of minutes from the September 22, 2026 meeting
- Decision on rescheduling the November 2026 meeting
- Assigning writing responsibilities for the legislative report
Who Should Pay Attention
- People affected by substance use disorders or seeking treatment services
- Healthcare providers, treatment programs, and social service organizations
- Families of youth or military members dealing with substance use issues
- Anyone interested in how Medicaid coverage for addiction services may be changing
- Community members who want to submit public testimony
To submit written testimony or request accessibility accommodations, contact Robyn Loudermilk at DOH.HACDACSChair@doh.hawaii.gov or (808) 692-8198.
How to Participate
This is a public meeting — all community members are welcome to attend and provide testimony. Meetings are typically held in person and may also be accessible online.